These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 36556962)

  • 61. Role of microbiota on lung homeostasis and diseases.
    Wang J; Li F; Tian Z
    Sci China Life Sci; 2017 Dec; 60(12):1407-1415. PubMed ID: 29019144
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dysbiosis of the gut and lung microbiome has a role in asthma.
    Hufnagl K; Pali-Schöll I; Roth-Walter F; Jensen-Jarolim E
    Semin Immunopathol; 2020 Feb; 42(1):75-93. PubMed ID: 32072252
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chronic obstructive pulmonary disease and infection. Disruption of the microbiome?
    Sethi S
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S43-7. PubMed ID: 24437405
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis.
    Avalos-Fernandez M; Alin T; Métayer C; Thiébaut R; Enaud R; Delhaes L
    Respir Res; 2022 Aug; 23(1):214. PubMed ID: 35999634
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Roles of the gut microbiota in severe SARS-CoV-2 infection.
    Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
    Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interactions between the lung microbiome and host immunity in chronic obstructive pulmonary disease.
    Zhu Y; Chang D
    Chronic Dis Transl Med; 2023 Jun; 9(2):104-121. PubMed ID: 37305112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Microbiota and microRNAs in lung diseases: mutual influence and role insights.
    Casciaro M; Di Salvo E; Pioggia G; Gangemi S
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13000-13008. PubMed ID: 33378051
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs.
    O'Shaughnessy M; Sheils O; Baird AM
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569672
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential Implications of the Lung Microbiota in Patients with Chronic Obstruction Pulmonary Disease and Non-Small Cell Lung Cancer.
    He JQ; Chen Q; Wu SJ; Wang DQ; Zhang SY; Zhang SZ; Chen RL; Wang JF; Wang Z; Yu CH
    Front Cell Infect Microbiol; 2022; 12():937864. PubMed ID: 35967848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.
    Wu BG; Segal LN
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28643622
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gut Microbiota Dysbiosis and Chronic Obstructive Pulmonary Disease: A Question of Chicken and Egg.
    Li N; Wang N; Ran P
    Am J Respir Crit Care Med; 2023 Dec; 208(11):1238-1240. PubMed ID: 37672767
    [No Abstract]   [Full Text] [Related]  

  • 74. The consequence of matrix dysfunction on lung immunity and the microbiome in COPD.
    Hussell T; Lui S; Jagger C; Morgan D; Brand O
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29950305
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Gut microbiota, immunity, and autoimmune diseases].
    Ohno H
    Rinsho Ketsueki; 2021; 62(8):900-908. PubMed ID: 34497229
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions.
    Borella F; Carosso AR; Cosma S; Preti M; Collemi G; Cassoni P; Bertero L; Benedetto C
    ACS Infect Dis; 2021 May; 7(5):987-1009. PubMed ID: 33848139
    [TBL] [Abstract][Full Text] [Related]  

  • 77. COPD and the microbiome.
    Mammen MJ; Sethi S
    Respirology; 2016 May; 21(4):590-9. PubMed ID: 26852737
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of Lung Microbiota on COPD.
    Russo C; Colaianni V; Ielo G; Valle MS; Spicuzza L; Malaguarnera L
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740358
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Intestinal microbiota, nutrients and probiotics viewed from the «gut-lung» axis].
    Zolnikova OY; Ivaschkin KV; Bueverova EL; Ivaschkin VT
    Vopr Pitan; 2019; 88(3):13-22. PubMed ID: 31265771
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis.
    Xu H; Zhao H; Fan D; Liu M; Cao J; Xia Y; Ju D; Xiao C; Guan Q
    Mediators Inflamm; 2020; 2020():1430605. PubMed ID: 32963490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.